NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Neuren approaching key milestones in Q4 2019, page-51

  1. 342 Posts.
    lightbulb Created with Sketch. 21
    Yeah I guess you are right

    For me I expect there will be an announcement in Q4

    I feel now I have to accept that it may be just about the progress of the final stage of testing of the major asset of NEU

    Makes sense really

    Win or Lose

    Sorry I can’t wait around for the outcome

    GLTA
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.